Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
In, Switzerland, doctors are prescribing museum visits as part of a revolutionary pilot project to enhance patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback